LA JOLLA PHARMACEUTICAL CO·5

Feb 9, 4:34 PM ET

LINNIK MATTHEW D 5

5 · LA JOLLA PHARMACEUTICAL CO · Filed Feb 9, 2005

Insider Transaction Report

Form 5
Period: 2004-12-31
LINNIK MATTHEW D
CSO & Exec VP of Research
Transactions
  • Other

    Common Stock

    2004-06-30$1.48/sh+539$7974,354 total
  • Other

    Common Stock

    2004-09-30$1.48/sh+455$6734,809 total
  • Gift

    Stock Option (right to buy)

    2004-11-09$4.13/sh2,254$9,298788,746 total
    Exercise: $0.00From: 2003-02-03Exp: 2008-02-03Common Stock (2,254 underlying)
  • Gift

    Stock Option (right to buy)

    2004-11-09$3.81/sh1,577$6,012787,169 total
    Exercise: $0.00From: 2003-04-08Exp: 2008-04-08Common Stock (1,577 underlying)
  • Other

    Common Stock

    2004-12-31$1.42/sh+555$7885,364 total
Holdings
  • Common Stock

    5,364
  • Stock Option (right to buy)

    Common Stock (787,169 underlying)
    787,169
Footnotes (2)
  • [F1]Acquired pursuant to the Company?s Employee Stock Purchase Plan.
  • [F2]Reporting only direct holdings, no transaction data is necessary

Documents

2 files
  • 5
    doc5.xmlPrimary

    FORM 5 SUBMISSION

  • EX-24.5_72148

    POA DOCUMENT